Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE-IVUS: Ezetimibe + Atorvastatin vs Atorvastatin in CAD
NCT01043380Phase 4Completed
- Sponsor
- Kumamoto University
- Start
- Jan 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in hypercholesterolemia and coronary artery disease (CAD), sponsored by Kumamoto University. Primary endpoint: Percent Atheroma Volume. Started Jan 2010; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemiacoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01043380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01043380.